These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 30513772)

  • 21. [The relationship between human papillomavirus and cyclin D1 gene amplification in squamous cell carcinomas of the head and neck].
    Rodrigo Tapia JP; García González LA; Alvarez Alvarez I; Cabanillas Farpón R; Suárez Nieto C
    Acta Otorrinolaringol Esp; 2005 Nov; 56(9):428-33. PubMed ID: 16353790
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Survival-Associated Metabolic Genes in Human Papillomavirus-Positive Head and Neck Cancers.
    Prusinkiewicz MA; Gameiro SF; Ghasemi F; Dodge MJ; Zeng PYF; Maekebay H; Barrett JW; Nichols AC; Mymryk JS
    Cancers (Basel); 2020 Jan; 12(1):. PubMed ID: 31968678
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NSD1 mutations by HPV status in head and neck cancer: differences in survival and response to DNA-damaging agents.
    Pan C; Izreig S; Yarbrough WG; Issaeva N
    Cancers Head Neck; 2019; 4():3. PubMed ID: 31321084
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low expression of NSD1, NSD2, and NSD3 define a subset of human papillomavirus-positive oral squamous carcinomas with unfavorable prognosis.
    Gameiro SF; Ghasemi F; Zeng PYF; Mundi N; Howlett CJ; Plantinga P; Barrett JW; Nichols AC; Mymryk JS
    Infect Agent Cancer; 2021 Feb; 16(1):13. PubMed ID: 33588906
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Analysis of key genes and signal pathways of human papilloma virus-related head and neck squamous cell carcinoma].
    Wang KP; Yuan YJ; Zhu JQ; Li BL; Zhang TT
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2020 Aug; 55(8):571-577. PubMed ID: 32842349
    [No Abstract]   [Full Text] [Related]  

  • 26. Genomic insights into head and neck cancer.
    Beck TN; Golemis EA
    Cancers Head Neck; 2016; 1():. PubMed ID: 29034103
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential anticancer activities of arsenic trioxide on head and neck cancer cells with different human papillomavirus status.
    Du S; Liu K; Gao P; Li Z; Zheng J
    Life Sci; 2018 Nov; 212():182-193. PubMed ID: 30243648
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular cytogenetic characterization of the 11q13 amplicon in head and neck squamous cell carcinoma.
    Jin C; Jin Y; Gisselsson D; Wennerberg J; Wah TS; Strömbäck B; Kwong YL; Mertens F
    Cytogenet Genome Res; 2006; 115(2):99-106. PubMed ID: 17065789
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular prognosticators in clinically and pathologically distinct cohorts of head and neck squamous cell carcinoma-A meta-analysis approach.
    Reddy RB; Khora SS; Suresh A
    PLoS One; 2019; 14(7):e0218989. PubMed ID: 31310629
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunological network analysis in HPV associated head and neck squamous cancer and implications for disease prognosis.
    Chen X; Yan B; Lou H; Shen Z; Tong F; Zhai A; Wei L; Zhang F
    Mol Immunol; 2018 Apr; 96():28-36. PubMed ID: 29477933
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gene signature for prediction of radiosensitivity in human papillomavirus-negative head and neck squamous cell carcinoma.
    Kim SI; Kang JW; Noh JK; Jung HR; Lee YC; Lee JW; Kong M; Eun YG
    Radiat Oncol J; 2020 Jun; 38(2):99-108. PubMed ID: 33012153
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PSMC2, ORC5 and KRTDAP are specific biomarkers for HPV-negative head and neck squamous cell carcinoma.
    Su Y; Zeng Z; Rong D; Yang Y; Wu B; Cao Y
    Oncol Lett; 2021 Apr; 21(4):289. PubMed ID: 33732365
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of Glial cell derived neurotrophic factor in head and neck cancer.
    Cao H; He Q; Eyben RV; Bloomstein J; Nambiar DK; Viswanathan V; Aggarwal S; Kwok S; Liang R; Koong AJ; Lewis JS; Kong C; Xiao N; Le QT
    PLoS One; 2020; 15(2):e0229311. PubMed ID: 32084217
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Amplification and overexpression of PPFIA1, a putative 11q13 invasion suppressor gene, in head and neck squamous cell carcinoma.
    Tan KD; Zhu Y; Tan HK; Rajasegaran V; Aggarwal A; Wu J; Wu HY; Hwang J; Lim DT; Soo KC; Tan P
    Genes Chromosomes Cancer; 2008 Apr; 47(4):353-62. PubMed ID: 18196592
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Head and neck squamous cell carcinoma: Ambiguous human papillomavirus status, elevated p16, and deleted retinoblastoma 1.
    Beck TN; Smith CH; Flieder DB; Galloway TJ; Ridge JA; Golemis EA; Mehra R
    Head Neck; 2017 Mar; 39(3):E34-E39. PubMed ID: 27859938
    [TBL] [Abstract][Full Text] [Related]  

  • 36. FGFR1 Is a Potential Prognostic Biomarker and Therapeutic Target in Head and Neck Squamous Cell Carcinoma.
    Koole K; Brunen D; van Kempen PM; Noorlag R; de Bree R; Lieftink C; van Es RJ; Bernards R; Willems SM
    Clin Cancer Res; 2016 Aug; 22(15):3884-93. PubMed ID: 26936917
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of Alternative Splicing Events in HPV-Negative Head and Neck Squamous Cell Carcinoma Identifies an Oncogenic DOCK5 Variant.
    Liu C; Guo T; Xu G; Sakai A; Ren S; Fukusumi T; Ando M; Sadat S; Saito Y; Khan Z; Fisch KM; Califano J
    Clin Cancer Res; 2018 Oct; 24(20):5123-5132. PubMed ID: 29945995
    [No Abstract]   [Full Text] [Related]  

  • 38. Proteomic Profiling Identifies PTK2/FAK as a Driver of Radioresistance in HPV-negative Head and Neck Cancer.
    Skinner HD; Giri U; Yang L; Woo SH; Story MD; Pickering CR; Byers LA; Williams MD; El-Naggar A; Wang J; Diao L; Shen L; Fan YH; Molkentine DP; Beadle BM; Meyn RE; Myers JN; Heymach JV
    Clin Cancer Res; 2016 Sep; 22(18):4643-50. PubMed ID: 27036135
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Peripheral blood monocyte and T-lymphocyte activation levels at diagnosis predict long-term survival in head and neck squamous cell carcinoma patients.
    Aarstad HJ; Vintermyr OK; Ulvestad E; Aarstad HH; Kross KW; Heimdal JH
    APMIS; 2015 Apr; 123(4):305-14. PubMed ID: 25801083
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Classical risk factors, but not HPV status, predict survival after chemoradiotherapy in advanced head and neck cancer patients.
    Descamps G; Karaca Y; Lechien JR; Kindt N; Decaestecker C; Remmelink M; Larsimont D; Andry G; Hassid S; Rodriguez A; Khalife M; Journe F; Saussez S
    J Cancer Res Clin Oncol; 2016 Oct; 142(10):2185-96. PubMed ID: 27370781
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.